ALNY vs AVGO · P/E 76, rev $1.29B vs P/E 87, rev $63.89B
Alnylam Pharmaceuticals Inc (ALNY) versus Broadcom Inc (AVGO) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Broadcom Inc (AVGO) is a semiconductors company listed on US. It is led by Hock E. Tan.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported AVGO revenue for 2025-11-02 was $63.89B. Net income was $23.13B. AVGO currently screens at market cap $2.12T and trailing P/E 86.9.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. AVGO currently screens at market cap $2.12T and trailing P/E 86.9.
Not investment advice. Open the ALNY and AVGO stock pages for the full models.
Not investment advice.